Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04566328
Title Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors ECOG-ACRIN Cancer Research Group
Indications

multiple myeloma

Therapies

Bortezomib + Daratumumab + Dexamethasone + Lenalidomide

Daratumumab + Lenalidomide

Daratumumab + Dexamethasone + Lenalidomide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.